TAG:
cap
Management Philosophy Drives UroCor’s Success
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
CEO SUMMARY: In the year 1997, UroCor shows a financial strength and growth potential unlike most commercial laboratories. UroCor’s current success is a direct result of how UroCor’s management did things differently during the years from 1991 to the present. Much of UroCor’s succes…
Market Assessment Leads Quest To Do Several Deals
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
CEO SUMMARY: Quest CEO Ken Freeman is moving rapidly to restructure Quest’s regional laboratory system. Using the financial head-start provided by the January spin-off from Corning, Inc., Quest purchased one laboratory and seeks to do joint venture deals in several cities. Quest’s act…
Pap Smear Technologies Battle For Market Share
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three compan…
National Lab Strategies Will Impact Competitors
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Not since the era of commercial lab consolidation ended has such a significant trend emerged. As the three national labs eliminate service to unprofitable accounts, profound changes will occur to the market for laboratory and pathology services. How quickly this leads to impr…
Lab Information Systems Meeting Highlights Innovation, Ideas
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Managed care’s pressure to create clinically integrated healthcare delivery systems changes the way laboratories report, use and warehouse clinical data. Dr. Bruce Friedman’s annual laboratory information systems conference in Ann Arbor provided graphic evidence that tech…
Roche Holdings, Ltd. Acquires Boehringer Mannheim In Merger
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Roche will pay $11 billion to buy Corange Ltd., parent company of Boehringer Mannheim, the world’s number two diagnostics company. Wall Street expects this deal to quicken the pace of consolidation in the healthcare industry. The surprise move will impact clinical laborator…
Ex-NHL Executives Buy American Medical Labs
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: American Medical Laboratories’ sale to new owners is a major event. Not only does the new management team have a reputation for top performance in selling clinical laboratory services, but they also arrive with an ample war chest. When the revamped AML hits the competitive …
Regional Lab Systems Beginning To Emerge
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: Regionalization of laboratory services is about to become a dominant industry trend. Four groups of players will drive this process and each needs to recruit hospital laboratories to participate in their regional model. This is the first generation of attempts to create finan…
New Hybrid Lab Systems Provide Peek At Future
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: As the first generation of regional laboratory systems begin operation, the marketplace is about to separate winners from losers. Stakes are high for hospital laboratory administrators. If they choose to affiliate with the wrong model, the consequences can cause extended disr…
Public Laboratories Struggling To Maintain Competitive Ability
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
WITH regional laboratory systems as the theme of this issue, it is appropriate to look at the three national laboratories. What does 1997 and 1998 hold in store for them? For the last three years, news was uniformly bad for virtually every public laboratory. Problems at Corning Clinical Labo…
CURRENT ISSUE
Volume XXXII, No. 15 – October 27, 2025
The Dark Report examines the momentous decision by the VA to switch accreditors from The Joint Commission to CAP. Also, we analyze retractions in pathology journals to gain insight into scientific fraud.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized